Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Regenerative Medical Technology Group

Tracked across 6 events · 39 articles · First seen Jul 23, 2026 · Last active Sep 21, 2026

Sentiment
11
Attention
1
Events
6
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
0 10
Business
Impact: Parent company executing strategic expansion into Argentina, expected to strengthen its Latin American presence.
Jul 23, 2026 · 6 articles
0 20
Business
Impact: RMTG is the central entity, hosting its first investor call to highlight strong first-half 2026 performance and engage shareholders. The event may enhance its credibility and investor relations.
Aug 05, 2026 · 9 articles
0 5
Business
Impact: RMTG is the central entity, having acquired the domain and launched the investor website as part of its investor-engagement strategy. This action may modestly improve shareholder communication and transparency.
Aug 26, 2026 · 6 articles
1 10
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Parent company announcing expansion; faces going-concern and liquidity issues.
Sep 08, 2026 · 6 articles
1 10
Business
Regenerative Medical Technology Group, Inc. (OTCID:RMTG) announced on September 17, 2026 the launch, through its ISSCA division, of a new Integrative Fellowship in Point-of-Care Regenerative Medicine. The fellowship is described as ISSCA's most comprehensive credential…
Impact: The company is the issuer of the announcement and the parent of Cell Stem Cell and ISSCA. The fellowship launch is intended to deepen physician relationships and create an educational pathway into ISSCA AI, but near-term financial impact is limited given the early commercialization stage.
Sep 17, 2026 · 6 articles
1 10
Business
Regenerative Medical Technology Group announced that its physician-education platform, the International Society for Stem Cell Application, will host the ISSCA 125 Global Summit from September 25-27, 2026 at the JW Marriott Cancun Resort and Spa…
Impact: The OTC-listed parent announced the summit through its subsidiary and frames it as a driver of physician education and commercial engagement. The event offers visibility but no disclosed financial figures, so any share-price effect is likely limited and sentiment-driven.
Sep 21, 2026 · 6 articles
David Christensen ↔ Regenerative Medical Technology Group
Cell Stem Cell parent ↔ Regenerative Medical Technology Group Regenerative Medical Technology Group wholly owns Cell Stem Cell, which function
David Christensen ceo ↔ Regenerative Medical Technology Group David Christensen is the Chief Executive Officer and President of Regenerative M
Cell Stem Cell subsidiary ↔ Regenerative Medical Technology Group Cell Stem Cell is a wholly owned operating subsidiary of Regenerative Medical Te
ERGEN INTELLIGENCE
Track Regenerative Medical Technology Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.